Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QLD vs GSK✓SelectedUSD · GSKQLD vs GSK performance historyLatest closeAs of-2.46%11/13
Stock and ETF performance explorer

QLD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+146.0%
GSK return
+65.8%
Excess return
+80.1%
Maximum drawdown
-42.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.5%+0.5%-3.0%-2.5%
7D+7.0%+1.1%+5.9%+6.9%
30D-14.3%+6.3%-20.7%-14.6%
3M-16.0%+1.8%-17.8%-16.0%
6M-14.2%+1.7%-15.9%-14.5%
YTD+12.8%+6.5%+6.2%+11.7%
1Y+14.1%+9.5%+4.6%+12.6%
3Y+146.0%+65.3%+80.7%+143.5%
All+146.0%+65.8%+80.1%+143.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling